Home
/
LIPELLA PHARMACEUTICALS INC.
/
Financials
/
Quarterly
LIPELLA PHARMACEUTICALS INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LIPELLA PHARMACEUTICALS INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$216.1K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$86.7K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$129.4K
May 14, 2025
Q3
2025
Sep 30, 2024
$80.4K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$136.4K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$145.9K
May 14, 2025
Q3
2024
Sep 30, 2023
$104.1K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$106.7K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$118.0K
May 9, 2024
Q3
2023
Sep 30, 2022
$33.1K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$33.1K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$33.1K
May 12, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.25M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.33M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($1.33M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($1.31M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($1.31M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($1.31M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.44M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($938.1K)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($938.1K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($1.19M)
May 14, 2025
Q2
2025
Mar 31, 2024
($1.19M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($1.19M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($1.32M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($1.54M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.54M)
Aug 13, 2024
Q2
2024
Mar 31, 2023
($1.07M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.07M)
May 9, 2024
Q3
2024
Mar 31, 2023
($1.07M)
Nov 14, 2024
Q3
2023
Dec 31, 2022
($2.60M)
Nov 14, 2023
Q1
2023
Dec 31, 2022
($2.60M)
May 12, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.27M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.36M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.33M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.46M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($952.2K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.22M)
May 14, 2025
Q3
2024
Sep 30, 2023
($1.36M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.58M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.08M)
May 9, 2024
Q3
2023
Sep 30, 2022
($712.6K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($781.1K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($736.7K)
May 12, 2023